OIS Retina Innovation Summit banner


7:30 - 8:30 AM

Check-in & Networking Breakfast

8:30 - 8:40 AM

Opening & Hot Topics in the Retina Space

Presented By:
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

8:40 - 8:50 AM

Winning Pitch Presentation

Presented By:
John S. Pollack, MD, Illinois Retina Associates / CMO - jCyte, Inc


Levent Akduman, MD, FASRS, CEO - Staphyloma Support Device

8:50 - 10:15 AM

Innovation Showcase

ReVive Biotechnology | Michael S. Tsipursky, MD, CEO

Rezolute | Rajat Agrawal, MD, Vice President, Clinical Development & Ophthalmology Lead

Vitranu | Gordon Bethwaite, CEO

Ingenia Therapeutics | Sangyeul Han, CEO

Opthea Limited | Joel Naor, MD, MSc, MBA, Chief Medical Officer

Anida Pharma | Per Gjorstrup, MD, PhD, President & CEO

Ripple Therapeutics | Tom Reeves, President & CEO

OcuTerra Therapeutics | Kerrie Brady, President & CEO

Opus Genetics | Ben Yerxa, PhD, CEO

Outlook Therapeutics | Russell Trenary, President & CEO

Ocuphire Pharma | Mina Sooch, MBA, CEO & Founder

Annexin Pharmaceuticals | Anders Haegerstrand, MD, PhD, CEO


10:15 - 10:45 AM

Morning Networking & Refreshment Break

10:45 - 11:45 AM

Spotlight on Dry AMD & GA

Iveric Bio | Keith Westby, Chief Operating Officer

Apellis | Federico Grossi, MD, Phd, Chief Medical Officer

ONL Therapeutics | David Esposito, President & CEO

Samsara Vision | Thomas Ruggia, CEO

Annexon Biosciences | Scott Borland, Vice President, Global Program Team Leader – Ophthalmology Franchise


Panel Discussion


David Boyer, MD - Retina Vitreous Associates Medical Group

Tarek S. Hassan, MD, Professor of Ophthalmology - Oakland University William Beaumont School of Medicine / Partner and Director of Vitreoretinal Training - Associated Retinal Consultants

Erin Henry, PhD, Executive Director, Head of Ophthalmology - NGM Biopharmaceuticals

J. Jill Hopkins, MD, SVP & Global Head, Ophthalmology Development Unit - Novartis


Moderated By:

Caroline R. Baumal, MD, Professor of Ophthalmology, Co-director of Retina Service - New England Eye Center, Tufts Medical Center

11:45 - 12:45 PM

Spotlight On Gene & Cell Therapy

REGENXBIO | Sherri Van Everen, PharmD, Vice President, Clinical Development

Eyevensys | Patricia Zilliox, PhD, CEO & President

SparingVision | Daniel Chung, MD, Chief Medical Officer

Kriya Therapeutics | Theresa Heah, MD, MBA, President & Chief Medical Officer - Kriya Ophthalmology

Endogena Therapeutics | Matthias Steger, PhD, MBA, Co-founder & CEO


Panel Discussion


Thomas M. Aaberg, Jr., MD, PhD, Retina Specialists of Michigan / CMO - Neurotech

Paul Bresge, CEO - Ray Therapeutics

Claire Gelfman, PhD, Chief Scientific Officer - Foundation Fighting Blindness

Glenn C. Yiu, MD, PhD, Professor - UC Davis Health Department of Ophthalmology & Vision Science


Moderated By:

John S. Pollack, MD, Illinois Retina Associates / CMO - jCyte, Inc

12:45 - 1:35 PM

Networking Lunch

1:35 - 2:35 PM

Spotlight on Drug Delivery & Durability

Eyepoint Pharmaceuticals | Nancy Lurker, President & CEO

Graybug | Frederic Guerard, CEO

Re-Vana Therapeutics | Michael O'Rourke, CEO

Clearside Biomedical | Thomas A. Ciulla, MD, MBA, Chief Medical Officer & Chief Development Officer

Oculinea | Robert B. Bhisitkul, MD, PhD


Panel Discussion


Thomas Ciulla, MD, MBA, Chief Medical Officer & Chief Development Officer - Clearside Biomedical / Clinical Professor of Ophthalmology, Volunteer - Indiana University School of Medicine / Vitreoretinal Medicine and Surgery - Midwest Eye Institute

Nancy Holekamp, MD, Director of Retina Services - Pepose Vision Institute

Michael Singer, MD, Clinical Professor of Ophthalmology - University of Texas, San Antonio


Moderated By:

Robert B. Bhisitkul, MD, PhD, Professor of Ophthalmology - University of California San Francisco School of Medicine

2:35 - 3:10 PM

Afternoon Networking & Refreshment Break

3:10 - 3:45 PM

Early-Stage Retina Drug Development Financing



David Esposito, President & CEO - ONL Therapeutics

James C. Murray, Partner - ExSight Ventures

Robert Rothman, MD, Co-Founder and Managing Member - InFocus Capital Partners / Partner - OCLI/Glaucoma Consultants of Long Island

Russell Trenary, President & CEO - Outlook Therapeutics


Moderated By:

Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

3:45 - 4:15 PM

The Impact of Successes and Failures in Retina



Greg Butz, Managing Director, Head of Life Sciences Investment Banking - Bank of America Merrill Lynch

David A. Eichenbaum, MD, Partner and Director of Research - Retina Vitreous Associates of Florida

Peter Kaiser, MD, Professor of Ophthalmology - Cole Eye Institute

Jerry Lee, MBA, Managing Director - Goldman Sachs


Moderated By:
Pravin U. Dugel, MD, President - Iveric Bio

4:15 - 5:15 PM

Spotlight on Breakthrough Technologies

RetinAI | Sandro De Zanet, PhD, Chief Scientific Officer

2C Tech | Jim Taylor, CEO

BVI/Beyeonics | Jorge Calzada, MD

Nanoscope Therapeutics | Samarendra Mohanty, PhD, Co-Founder, President & Chief Scientific Officer


Panel Discussion

Pierre Billardon, CEO - DORC International B.V.

Paul Hallen, VP & Global Head, Retina - Alcon

Jean-Pierre Hubschman, MD, Professor of Ophthalmology and Engineering - Stein Eye Institute at UCLA

Aaron Nagiel, MD, PhD, Assistant Professor of Ophthalmology - Keck School of Medicine of USC


Moderated By:

Mark Humayun, MD, PhD, Professor of Ophthalmology and Director - University of Southern California Roski Eye Institute

5:15 - 5:30 PM

Closing Remarks & Award Presentations

5:30 - 6:30 PM

Networking reception